Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimatoprost 0.01% in POAG or Ocular Hypertension
NCT01594970Phase 4Completed
- Sponsor
- Allergan
- Start
- Mar 2012
- Primary completion
- Jan 2013
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 4 trial of bimatoprost in primary open-angle glaucoma (POAG), ocular hypertension, sponsored by Allergan. Started Mar 2012; status: completed.
02
Drugs
bimatoprost
03
Conditions
primary open-angle glaucoma (POAG)ocular hypertension
Beyond the preview
Go deeper on NCT01594970.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01594970.